| 日 期 | 主 題 | 作者 |
|---|---|---|
| 2023-01-12 | Taiwan business watch 2022: Biomedical sector top 20 by revenue and segment | |
| 2022-07-14 | Taiwan Business Watch H1, 2022: Biomedical Sector | |
| 2022-07-01 | Salary 2021: Non-Managerial Employees in Taiwan’s Biomedical Sector | There were 15 companies with the pay per annum over and well over 1M in Taiwan Dollar (TWD) and the other 14 with a double-digit salary growth. |
| 2022-05-18 | Taiwan business watch Q1, 2022: Biomedical sector | |
| 2022-04-22 | Taiwan business watch 2021: Biomedical company profitability | |
| 2022-04-20 | Covid-19: FDA authorised and approved drugs and non-vaccine biological products | |
| 2022-01-13 | Taiwan business watch 2021: Biomedical top 20 | IBMI & RBMP |
| 2022-01-06 | Taiwan business watch 2021: Biomedical IPOs fueled by 24 new comers | Companies in 2021 with stocks publicly traded climbed to 107- a paramount number in three years past- of nearly a quarter (24) from the biomedical sector. |
| 2021-10-19 | Taiwan business watch Q1 to Q3, 2021: Biomedical sector | The biomedical sector revenue totalled $234.3bn, up by 12.8% compared to Q1 to Q3 last year. The growth rate, however, was lower than 18.3% the average by the overall listed and OTC companies. |
| 2021-09-16 | Covid-19 New Drugs Race: Overview of Global R&D Progress | According to Clinical.gov, more than 700 new drugs against Covid-19 developed and registered by companies worldwide are undergoing Phase 2 and Phase 3 clinical trials. More than 500 clinical trials are underway around the globe with unprecedented competition. |
